Clinically validated assay for rapid determination of type I and type II interferon activity in systemic inflammatory diseases
Michael T. Lam(Boston Children's Hospital), Pui Y. Lee(Boston Children's Hospital), Christian Wysocki(Southwestern Medical Center), Mary Beth F. Son(Boston Children's Hospital), Roshini S. Abraham(Nationwide Children's Hospital), Kailey Brodeur(Boston Children's Hospital), Seigo Okada(Boston Children's Hospital), Casey A. Rimland(Brigham and Women's Hospital), Holly Wobma(Boston Children's Hospital), Joyce C. Chang(Boston Children's Hospital), Evan E. Hsu(Boston University), Courtney E LeSon(Boston Children's Hospital), Anusha Ramanathan(Kaiser Permanente), Janet Chou(Boston Children's Hospital), Xiao P. Peng(Children's Hospital at Montefiore), Zhengping Huang(Guangdong Provincial People's Hospital), Jian Yue(Guangdong Provincial People's Hospital), Connie L. Jiang(Boston Children's Hospital), Craig D. Platt(Boston Children's Hospital), Lauren A. Henderson(Boston Children's Hospital), Musaab A. Alhezam(Boston Children's Hospital), Amrita Basu(Nationwide Children's Hospital), Rachel Weng(Boston Children's Hospital), Milena M. Andzelm(Boston Children's Hospital)
Cited by 3
Related Papers
Multisystem Inflammatory Syndrome in U.S. Children and Adolescents
|New England Journal of Medicine|2020|2.7k
American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV‐2 and Hyperinflammation in Pediatric COVID‐19: Version 1
|Arthritis & Rheumatology|2020|537